Recombinant Caldesmon antibody (full length)
Quick Overview for Recombinant Caldesmon antibody (full length) (ABIN7877758)
Target
See all Caldesmon (CALD1) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Recombinant Caldesmon Antibody / CAD / CALD1 (HMW)
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human CALD1 protein was used as the immunogen for the recombinant Caldesmon antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant Caldesmon antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the recombinant Caldesmon antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Caldesmon (CALD1) (Caldesmon 1 (CALD1))
-
Alternative Name
- Caldesmon
-
Background
- Recognizes a protein of 150 kDa, which is identified as the high molecular weight variant of Caldesmon. Two closely related variants of human caldesmon have been identified which are different in their electrophoretic mobility and cellular distribution. The h-caldesmon variant (120-150 kDa) is predominantly expressed in smooth muscle whereas l-caldesmon (70-80 kDa) is found in non- muscle tissue and cells.
-
UniProt
- Q05682
-
Pathways
- Myometrial Relaxation and Contraction
Target
-